We are proud to announce that Dr. Keyue Sun and the Schlegel Lab have been selected as the inaugural recipients of the NADMED Award for their work on metabolic assessment of organ viability in transplantation. Their research tackles a critical question in transplant...
NADMED has partnered with London-based Altheome Labs to expand access to advanced NAD testing in the UK, marking another step in the company’s international growth. Through this collaboration, NADMED’s CE-marked NAD measurement technology will be integrated into...
A new abstract, presented at the American Stroke Association’s Conference, explores how NAD and NADP, critical molecules for cellular energy and repair, change in the early days after stroke and what that might mean for recovery. Preliminary findings (n=18) showed: •...
A study in Cell Reports Medicine shows significantly lower NAD+ levels in the brains of Alzheimer’s patients, especially in the parietal and occipital regions. The findings highlight a strong correlation between NAD+ depletion and mitochondrial dysfunction,...
Affinity Biomarker Labs, based in London, UK, is the latest partner to join the NADMED network, offering NAD+ and NADH testing upon request. Established in 2017 at Imperial College London’s White City Campus, Affinity Biomarker Labs was founded by a team of clinical...
